Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance
F Calapai, C Mannucci, M Currò, L Cardia, E Esposito… - Pharmaceuticals, 2024 - mdpi.com
Background: Evolocumab is a humanized immunoglobulin G2 monoclonal antibody,
directed against Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9), prescribed in …
directed against Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9), prescribed in …